Veeda Clinical Research Limited · Health Care · Veeda Clinical Research Unlisted / Pre-IPO Share Price
As of 29 Oct 2026, the Veeda Clinical Research Limited unlisted share price is ₹428 per share. Implied valuation: ₹2,990 Cr. Veeda Clinical Research Limited is an unlisted / pre-IPO company — not listed on NSE or BSE. Minimum investment: ₹50,000. ISIN: INE01HQ01026.
▼ ₹132 (−23.57%) over all time
Key figures for Veeda Clinical Research Limited
Veeda Clinical Research Limited is an Indian contract research organization providing clinical trial services including bioequivalence, early-phase, late-phase and pharmacovigilance. Headquartered in Ahmedabad with multiple facilities, Veeda serves global and domestic pharmaceutical companies and has conducted thousands of studies across therapeutic areas. The company emphasizes quality systems, volunteer safety, data integrity and regulatory compliance, with accreditations/inspections from multiple agencies.
| Particulars | FY22 | FY23 | FY24 | FY25 | FY26 LATEST |
|---|---|---|---|---|---|
| Revenue | 288 | 409 | 388 | 610 | 715.5▲17% |
| EBITDA | 62 | 103 | 53 | 125 | 209.6▲68% |
| OPM (%) | 21.53% | 25.18% | 13.66% | 20.49% | 29.29%▲43% |
| PBT | 65 | 59 | 3.3 | -66 | 7.3▲111% |
| PAT | 50 | 42 | -0.3 | -67 | -14▲79% |
| EPS (₹) | ₹9.46 | ₹8 | ₹-0.04 | ₹-10.19 | ₹-2▲80% |
Figures in ₹ Crore unless marked ₹ (per share) or %. Source: company filings via unlistedzone.
Veeda Clinical Research shares are unlisted, so they are bought off-market through a SEBI-registered intermediary rather than on the NSE or BSE. With Safal Capital the process is simple:
No. Veeda Clinical Research is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE and there is no live “Veeda Clinical Researchshare price NSE”. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Veeda Clinical Research has not announced a confirmed IPO date. Investors buy unlisted shares ahead of a potential listing for pre-IPO upside, but a listing is never guaranteed and timelines can change. The ISIN for Veeda Clinical Research is INE01HQ01026. Contact our desk for the latest status and a live quote before you invest.
Veeda Clinical Research Limited is an unlisted company operating in the Health Care sector (Clinical Research Organization (CRO)). Veeda Clinical Research Limited is an Indian contract research organization providing clinical trial services including bioequivalence, early-phase, late-phase and pharmacovigilance. Headquartered in Ahmedabad with multiple facilities, Veeda serves global and domestic pharmaceutical companies and ha…
The current unlisted market price is ₹423.72 per share with a market capitalisation of approximately ₹2815 crore. The company is currently unlisted and investors should factor in illiquidity risk and longer holding horizons. Investors are advised to review the full financial data and consult an advisor before investing.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
Latest source-linked updates that may be relevant to this company.
Restaurant Brands Asia Q2 FY27 slides: India drives 281% EBITDA surge By Investing.com Investing.com India
Stock markets witness bull-run, Sensex gains over 900 points The Statesman
Infobay AI Raises Again: Kacholia, Bajaj Finance on Board UnlistedZone
As of 29 Oct 2026, the Veeda Clinical Research unlisted (pre-IPO) share price is ₹428 per share on Safal Capital. Unlisted share prices move with demand, supply and deal size, so contact our desk for a live, deal-specific quote before you transact.
At the unlisted share price of ₹428, Veeda Clinical Research's implied market valuation is about ₹2,990 Cr (share price × total shares outstanding). This is an indicative, market-implied figure that moves with the unlisted price — not an official company valuation.
You buy Veeda Clinical Research unlisted shares off-market through a SEBI-registered intermediary. With Safal Capital: (1) share your requirement and quantity, (2) we confirm the live price and availability, (3) you complete KYC, (4) transfer funds, and (5) the shares are credited to your demat account, usually within T+1 to T+2 working days.
No. Veeda Clinical Research is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Veeda Clinical Research has not announced a confirmed IPO date. Unlisted shares are often bought before a potential listing in the hope of pre-IPO gains, but a listing is never guaranteed and timelines can change. Speak to our advisors for the latest status on Veeda Clinical Research.
The ISIN for Veeda Clinical Research unlisted shares is INE01HQ01026. You will need this ISIN when the shares are credited to your demat account.
Veeda Clinical Research unlisted shares have a face value of ₹2 and a typical minimum lot of 100 shares. Minimum quantities can vary with availability and deal size — our desk will confirm the current lot before you invest.
Unlisted share prices are not set by an exchange. The Veeda Clinical Research price reflects recent off-market deals, buyer/seller demand, the company's financials and expectations around a future IPO. Because it is over-the-counter, always confirm a live quote before transacting.
Unlisted shares like Veeda Clinical Research can offer pre-IPO upside but carry higher risk and lower liquidity than listed stocks, and there is no guaranteed exit. Invest only after reviewing the company's fundamentals and your risk profile — Safal Capital's SEBI-registered advisors can help you assess Veeda Clinical Research.
Unlisted shares like Veeda Clinical Research are high-growth but illiquid. Balance them with these — all with the same SEBI-registered team.
